Denmark

Dashboard Indicators

  • Long-term Control of Eczema Symptoms

    Scores are based on responses to the AD Control Tool: https://www.adcontroltool.com/adct-how-to-use/adct-in-clinical-practice

    Data source: GPIIEC global survey of 3,253 patients and caregivers, 2022.

  • Satisfaction with Eczema Treatments

    Self reported satisfaction with current treatments (caregivers and adults).

    Data source: GPIIEC global survey of 3,253 patients and caregivers, 2022.

  • Life Span Trade-Off (Health Utility)

    Percent of remaining life span adult patients would trade off in order to be restored to perfect health. (Derived from EQ5D Utility Scores).

    Data source: GPIIEC global survey of 3,253 patients and caregivers, 2022.

  • Eczema Patients Self Reported Health to Compared to Country Average

    Self-rated quality of life score for the average person compared to the self-rated quality of life score for adults with eczema.

    Data source: GPIIEC survey of 3,253 patients and caregivers, 2022.

  • Dimensions of Health – Relative Impact (Adults)

    Data source: GPIIEC global survey of 3,253 patients and caregivers, 2022.

  • Financial Burden – Impacts

    Percent of respondents (adults and caregivers) who reported using savings, borrowing money and/or reducing spending due to eczema. Higher = More Financial Impact

    Data source: GPIIEC global survey of 3,253 patients and caregivers, 2022.

  • Shared Decision Making

    The percentage of respondents who indicated that the healthcare provider whom they see for eczema asked about their priorities for their eczema care at the most recent visit.

    Data source: GPIIEC global survey of 3,253 patients and caregivers, 2022.

  • Eczema Education and Training

    Respondents who said a health care provider had ever suggested they attend an eczema training program that happens after the office visit.

    Data source: GPIIEC global survey of 3,253 patients and caregivers, 2022.

  • Access to Dermatologists

    Denmark ranks 7th out of the 10 countries studied on this measure.

    Source: Dam , Tomas N, et al. “Modernisering Af Specialet Dermato-Venerologi .” Foreningen Af Praktiserende Speciallæger (FAPS) , Apr. 2018.

  • Evidence-Based Guidelines

    Denmark ranks 7th out of the 8 countries on the quality of its guidelines for AD. Future guidelines should include a clear methodology and include patient and/or caregiver input.

    Scoring criteria for the guideline measure >

    Source: Deleuran , Mette, et al. “AD Guideline.” Dansk Dermatologisk Selskab, 24 Nov. 2020, dds.nu/retningslinjer/ad-guideline-oktober-2020/.

Literature Review Key Findings

 

The prevalence of AD is similar in Denmark and other western European nations. Much like in the US, multiple recent studies have evaluated comorbid associations, including those that may have consequences of AD therapy.

Fears about topical corticosteroid use in both patients and caregivers are well-characterized in the Danish literature. Much like in Canada, Danish parents of children with AD preferred to receive care from dermatologists rather than from GPs. The impacts of AD on missed work, the choice of work, and the timing of retirement were also well-represented in the Danish literature, and other countries may find it useful to conduct similar assessments of these impactful and yet often forgotten consequences of AD. 

Learn more about the findings gathered from the Denmark literature review.